(Circulation. 2006;114:1372-1379.)
© 2006 American Heart Association, Inc.
Congenital Heart Disease |
From the Department of Medicine, VA Medical Center and University of Minnesota, Minneapolis (Z.H., J.A.C., A.V., D.P.N., E.K.W.); Department of Anesthesiology, Beijing Friendship Hospital, affiliated with Capital University of Medical Science, Beijing, China (F.H.); and Experimental Anesthesiology, Department of Anesthesiology, University of Graz Medical School, Graz, Austria (A.O.).
Correspondence to E. Kenneth Weir, MD, VA Medical Center 111C, One Veterans Dr, Minneapolis, MN 55417. E-mail weirx002{at}umn.edu
Received November 2, 2005; de novo received May 19, 2006; revision received July 24, 2006; accepted July 27, 2006.
| Abstract |
|---|
|
|
|---|
Methods and Results Using ductus ring experiments, calcium imaging, reverse-transcription polymerase chain reaction, Western blot, and cellular electrophysiology, we find that this depolarization-independent contraction is caused by release of calcium from the IP3-sensitive store in the sarcoplasmic reticulum, by subsequent calcium entry through store-operated channels, and by increased calcium sensitization of actin-myosin filaments, involving Rho-kinase.
Conclusions Much of the normoxic contraction of the ductus arteriosus at birth is related to calcium entry through store-operated channels, encoded by the transient receptor potential superfamily of genes, and to increased calcium sensitization. A clearer understanding of the mechanisms involved in normoxic contraction of the ductus will permit the development of better therapy to close the patent ductus arteriosus, which constitutes
10% of all congenital heart disease and is especially common in premature infants.
Key Words: ductus arteriosus, patent heart defects, congenital ion channels oxygen vasoconstriction
| Introduction |
|---|
|
|
|---|
Clinical Perspective p 1379
| Methods |
|---|
|
|
|---|
Calcium Imaging
Dual-excitation imaging with Fura2 was used to measure the cytosolic Ca2+ response to changes in oxygen tension in freshly dispersed DASMCs as previously described.8 TRPC1 antibody (Alomone Laboratories, Jerusalem, Israel) binds amino acids 557 to 571 on the S5 pore-forming region of TRPC1 on the extracellular domain and inhibits Ca2+ entry via this channel.1214 DASMCs were exposed to anti-TRPC1 (all in 1:200), TRPC1 peptide/anti-TRPC1 mixture (1 µg: 1 µg), or saline for 1 hour and then loaded with Fura2-AM.
Cell Electrophysiology
Conventional whole-cell patch-clamp studies were performed on freshly isolated DASMCs as previously described8 to record the calcium current elicited by emptying the sarcoplasmic reticulum (SR) pharmacologically or by switching from hypoxia to normoxia. Two voltage-clamp protocols were used in current studies. One used continuous current recording while holding the cells at a membrane potential of 80 mV during an intervention. The second protocol held the cell membrane potential at 0 mV, and currents were then evoked by 400-ms pulses in 20-mV steps from 120 to 60 mV at 10-second intervals.
Reverse-Transcription Polymerase Chain Reaction
RNA was extracted from DA after endothelium and adventitia had been removed. After reverse transcription (RT), cDNA samples were amplified and densitometry was used to quantify the polymerase chain reaction (PCR) product relative to ß-actin (details online). Oligonucleotide primers used to amplify TRPC1-C7 in the DASMCs are shown in the Table.
|
Western Blot
Polyclonal primary antibodies (TRPC1, TRPC3, TRPC4, TRPC5: 1:200; TRPC6: 1:400; Alomone) were used to identify these channel proteins in the membranes of fetal rabbit DA, fetal rat brain, and rat brain. The specificity of the antibody for the intended antigen was confirmed in competitive experiments in which incubation with an excess of the relevant antigen neutralized the antibody. Western blots were performed using protein samples pooled from DA tissue taken from 20 fetal rabbits (see Data Supplement).
Statistical Analysis
Data are expressed as mean±SEM. In all figures, the SEM is indicated when it exceeds the symbol size. The effects of drugs on current, intracellular Ca2+ levels, and DA tension were assessed by separate factorial ANOVAs with post hoc analysis (Fishers least-significant-difference test). The specific factors, drugs, and drug levels are given in the figures and figure legends. Values of P<0.05 were considered significant.
All studies were approved by the Institutional Animal Care and Use Committee of the Minneapolis Veterans Affairs (VA) Medical Center and conform to current National Institutes of Health and American Physiology Society guidelines for the use and care of laboratory animals.
The authors had full access to the data and take full responsibility for their integrity. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
Cyclopiazonic acid (CPA), which inhibits SR Ca2+ adenosine triphosphatase and depletes the calcium store by preventing calcium uptake, causes a contraction of 1079±123 mg (n=8) (Figure 1C). The superimposed contraction to normoxia is 37±7% of the control contraction to normoxia. Omission of calcium from the ring bath or addition of the SOC blockers 2-APB (30 µmol/L) or SKF96365 (10 µmol/L) decreases normoxic DA contraction to 19±5%, 34±8%, and 44±6%, respectively (Figure 1D), suggesting that a substantial part of the normoxic contraction is related to SOC calcium influx. A role for other mechanisms appears less likely because the following agents had no effect: 10 µmol/L ruthenium red (blocker for TRPV family), 96±6% of control (n=6) (Figure 1D); 200 nmol/L menthol (TRPM8 agonist), 103±1% of control (n=3); 3 µmol/L BIS-1 (protein kinase C blocker), 98±3% of control (n=5); and 100 nmol/L H89 (PKA blocker) 92±4% of control (n=5).
When calcium stores in the SR are depleted by thapsigargin (TG; 100 nmol/L), L-type calcium channels are blocked by nifedipine, and the bath solution contains no calcium, switching the DA ring from hypoxia to normoxia causes only a small contraction (Figure 2A). When 2 mmol/L calcium is introduced during hypoxia, there is a contraction, and then switching to normoxia stimulates a further marked contraction, presumably related to influx of calcium through SOCs, although increased calcium sensitization cannot be excluded.
|
In DA rings treated with nifedipine (l µmol/L), switching the bath calcium from 0 to 2 mmol/L causes a much greater contraction under normoxic conditions than when the same switch is made under hypoxic conditions (P<0.001; Figure 2B). This was true whether the normoxic or the hypoxic exposure was made first. Thus, in this experiment, normoxia appears to facilitate calcium release and/or calcium entry through the SOCs. Concordant with this observation, measurement of cytosolic calcium in DASMCs in the presence of nifedipine (l µmol/L) shows that the calcium level is higher in normoxia (Figure 3A).
|
The presence of SOCs is illustrated by the rise in calcium on switching from 0 to 2 mmol/L calcium in the presence of CPA and nifedipine during normoxia (Figure 3B). Using TRPC1 antibody significantly reduces the calcium rise on switching from 0 to 2 mmol/L calcium, suggesting that TRPC1 may play an important role in the SOCs of DASMCs (Figure 3B). The TRPC subfamily of transient receptor potential (TRP) channels is thought to be responsible for store-operated calcium influx. mRNA for TRPC1, TRPC3, TRPC4, and TRPC6 is identified in DA by reverse transcription polymerase chain reaction (Figure 4A). Both rabbit and mouse TRPC1 primers were used. In addition, TRPC1 and TRPC4 proteins were detected in DA by Western blot (Figure 4B). The physiological function of SOCs was confirmed in patch-clamp experiments with DASMCs. The introduction of CPA or normoxia elicits an inward current when the membrane potential of the SMC is clamped at 80 mV (Figure 5A). Similarly, when the calcium current is isolated by inhibition of chloride and potassium currents, both CPA and normoxia markedly enhance the current across a range of membrane potentials (Figure 5B and 5C).
|
|
Calcium sensitization is a critical mechanism in the modulation of vascular tone. Therefore, we examined the role of calcium sensitization in normoxic contraction in DA rings. The role of calcium sensitization in normoxic contraction was studied in DA rings. The Rho-kinase inhibitor Y-27632 (3 µmol/L) reduces normoxic DA ring tone below baseline, whether given during or before the introduction of normoxia. With washout of Y-27632, normoxic contraction recovers very rapidly (Figure 6A and 6B). Fasudil, a structurally dissimilar inhibitor of Rho-kinase, also reduces normoxic DA tone (Figure 6B). In the case of SOC-related contraction induced by switching from 0 to 2 mmol/L calcium in the presence of CPA and nifedipine during hypoxia, Y-27632 again reduces DA ring tone to below the baseline, whether given before the calcium switch or during the contraction (Figure 6C). After pretreatment, the 2-mmol/L calcium contraction is greatly reduced (P<0.001) (Figure 6C). In KCl-induced contraction, Y-27632 blocks 74±12% when given during the contraction. After pretreatment and the subsequent lowered baseline tension, the KCl-induced contraction also is reduced (P<0.05) (Figure 6D). In control experiments, the Rho-kinase inhibitor Y-27632 (3 µmol/L) has no effect on K+ current over the range of 70 to 50 mV or on membrane potential (n=6 for both; online Figure I).
|
| Discussion |
|---|
|
|
|---|
If release from the SR contributes to normoxic contraction, what is the evidence for calcium entry through SOC? The presence in the DA of at least TRPC1 and TRPC4 is indicated by the finding of mRNA and protein by reverse transcription polymerase chain reaction and Western blot (Figure 4). TRPC1 forms part of the SOCs in pulmonary artery SMCs,2629 and TRPC1 mRNA is expressed in mouse, rabbit, and human resistance pulmonary arteries.30 Similarly, TRPC4 has been detected in rat pulmonary artery smooth muscle.27,31 However, these channels have not previously been described in the DA. In terms of function, the involvement of SOCs is indicated by the observation that, in the presence of nifedipine to inhibit influx through the L-type calcium channel and TG to deplete the IP3 calcium store, a switch from 0 to 2 mmol/L calcium in the DA ring tissue bath during hypoxia results in an increase in tone. This indicates calcium entry through the SOC. Further contraction on switching from hypoxia to normoxia (Figure 2A) suggests that normoxia facilitates calcium entry through SOCs because the SR is already depleted by TG; therefore, the oxygen level should not affect the calcium release from the SR. The observation that changing the ring bath from 0 to 2 mmol/L calcium under hypoxic conditions in the presence of nifedipine causes only a small increase in tone indicates that the release of calcium and/or SOC calcium entry is small during hypoxia. It also could be that the cytosolic calcium falls below a critical threshold level necessary for calcium sensitization. Under normoxic conditions, the same change from 0 to 2 mmol/L calcium causes a large increase in tone (Figure 2B), implying that normoxia markedly increases calcium release and/or SOC calcium entry. These in turn may bring calcium sensitivity back into play. Further evidence for the increased SOC current during normoxia comes from the measurement of the calcium current in the presence of blockers of potassium and chloride channels (Figure 5). The inward calcium current at negative potentials was markedly enhanced during exposure to normoxia. The current-voltage relationship is characteristic of SOC rather than L-type calcium currents. The SOC current can be linked to TRP channels by the finding that incubation of DASMCs with an antibody to TRPC113 will inhibit calcium entry caused by switching from 0 to 2 mmol/L external calcium in the presence of CPA and nifedipine (Figure 3B). Another observation linking SOC current to TRP channels is the recording of an inward SOC current in HEK 293 cells overexpressing TRPC1 while clamped at 80 mV and stimulated by CPA (30 µmol/L) (online Figure II). This current could not be elicited on wild-type HEK 293 cells or cells overexpressing TRPC4
. Reports that overexpression of TRPC1 can increase SOC and that SiRNA knockdown of TRPC1 will reduced SOC support this concept.29,32
The sensitivity of actin-myosin to any particular level of cytosolic calcium is an important determinant of vascular tone. Contraction is initiated when myosin light chain is phosphorylated. Dephosphorylation by myosin phosphatase causes relaxation. The myosin phosphatase can be inhibited through phosphorylation by Rho-kinases; thus, Rho-kinases may increase contraction, even at a fixed calcium concentration.33 Inhibition of Rho-kinases with agents such as Y-27632 or fasudil may cause vasodilatation and indicate whether calcium sensitization is playing a significant role. Y-27632 and fasudil both ablate the normoxic contraction of the DA, regardless of whether they are given before normoxic contraction (pretreatment) or during contraction (posttreatment) (Figure 6A and 6B). These agents also ablate DA contraction caused by other stimuli (Figure 6C and 6D), indicating that the source of calcium-initiating contraction is immaterial. The efficacy of these agents, if they are specific for Rho-kinase, highlights the importance of the calcium sensitization mechanism in the DA. In terms of specificity, Y-27632 has no effect on whole-cell K+ current or membrane potential. In summary, the novel finding in these experiments is the observation of SOC current in DASMCs that is markedly enhanced by normoxia and correlates with the functional ring studies and the finding of TRPC channels in the DA. These results, together with new observations on calcium sensitization, introduce mechanisms that can be pharmacologically manipulated to help close or open the DA as clinically indicated.
| Acknowledgments |
|---|
were a gift from Dr Mike Zhu, Ohio State University, Columbus. Sources of Funding
This work was supported by VA Merit Review Funding and National Institutes of Health grant RO1 HL 65322.
Disclosures
None.
| References |
|---|
|
|
|---|
2. Born GV, Dawes GS, Mott JC, Rennick BR. The constriction of the ductus arteriosus caused by oxygen and by asphyxia in newborn lambs. J Physiol. 1956; 132: 304342.
3. Alzamora-Castro V, Battilana G, Abugattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol. 1960; 5: 761763.[CrossRef][Medline] [Order article via Infotrieve]
4. Fineman JR, Takahashi Y, Roman C, Clyman RI. Endothelin-receptor blockade does not alter closure of the ductus arteriosus. Am J Physiol. 1998; 275: H1620H1626.[Medline] [Order article via Infotrieve]
5. Michelakis E, Rebeyka I, Bateson J, Olley P, Puttagunta L, Archer S. Voltage-gated potassium channels in human ductus arteriosus. Lancet. 2000; 356: 134137.[CrossRef][Medline] [Order article via Infotrieve]
6. Tristani-Firouzi M, Reeve HL, Tolarova S, Weir EK, Archer SL. Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J Clin Invest. 1996; 98: 19591965.[Medline] [Order article via Infotrieve]
7. Reeve HL, Tolarova S, Nelson DP, Archer S, Weir EK. Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol. 2001; 533: 253261.
8. Olschewski A, Hong Z, Peterson D, Nelson DP, Porter VA, Weir EK. Opposite effects of redox status on membrane potential, cytosolic calcium, and tone in pulmonary arteries and ductus arteriosus. Am J Physiol Lung Cell Mol Physiol. 2004; 286: L15L22.
9. Archer S, Wu XC, Thebaud B, Moudgil R, Hashimoto K, Michelakis ED. O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide. Biol Chem. 2004; 385: 205216.[CrossRef][Medline] [Order article via Infotrieve]
10. Hermes-DeSantis ER, Clyman R. Patent ductus arteriosus: pathophysiology and management. J Perinatol. 2006; 26: S14S18.[CrossRef][Medline] [Order article via Infotrieve]
11. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med. 2000; 343: 728730.
12. Liu X, Singh BB, Ambudkar IS. TRPC1 is required for functional store-operated Ca2+ channels. J Biol Chem. 2003; 278: 1133711343.
13. Ahmmed GU, Mehta D, Vogel S, Holinstat M, Paria BC, Tiruppathi C, Malik AB. Protein kinase C
phosphorylates the TRPC1 channel and regulates store-operated Ca2+ entry in endothelial cells. J Biol Chem. 2004; 279: 2094120949.
14. Jho D, Mehta D, Ahmmed G, Gao XP, Tiruppathi C, Broman M, Malik AB. Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2+ influx. Circ Res. 2005; 96: 12821290.
15. Graham TP Jr, Atwood G, Boucek RJ Jr. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease. South Med J. 1978; 71: 12381241, 1246.
16. Weir EK, Matisonn RE, Losman E, Chesler E. Prostaglandin E1 in infants with pulmonary atresia. S Afr Med J. 1978; 54: 700702.[Medline] [Order article via Infotrieve]
17. Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev. 1998; 50: 3558.
18. Waleh N, Kajino H, Marrache AM, Ginzinger D, Roman C, Seidner SR, Moss TJ, Fouron JC, Vazquez-Tello A, Chemtob S, Clyman RI. Prostaglandin E2-mediated relaxation of the ductus arteriosus: effects of gestational age on G proteincoupled receptor expression, signaling, and vasomotor control. Circulation. 2004; 110: 23262332.
19. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR, Lord EM, Weiss H, Waleh N, Evans SM, Koch CJ. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the role of prenatal constriction, hypoxia, and gestation. Pediatr Res. 1999; 45: 1929.[Medline] [Order article via Infotrieve]
20. Coceani F, Liu Y, Seidlitz E, Kelsey L, Kuwaki T, Ackerley C, Yanagisawa M. Endothelin A receptor is necessary for O2 constriction but not closure of ductus arteriosus. Am J Physiol. 1999; 277: H1521H1531.[Medline] [Order article via Infotrieve]
21. Keck M, Resnik E, Linden B, Anderson F, Sukovich DJ, Herron J, Cornfield DN. Oxygen increases ductus arteriosus smooth muscle cytosolic calcium via release of calcium from inositol triphosphate-sensitive stores. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L917L923.
22. Thebaud B, Michelakis ED, Wu XC, Moudgil R, Kuzyk M, Dyck JR, Harry G, Hashimoto K, Haromy A, Rebeyka I, Archer SL. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation. 2004; 110: 13721379.
23. Casteels R, Droogmans G. Exchange characteristics of the noradrenaline-sensitive calcium store in vascular smooth muscle cells or rabbit ear artery. J Physiol. 1981; 317: 263279.
24. Clapham DE, Runnels LW, Strubing C. The TRP ion channel family. Nat Rev Neurosci. 2001; 2: 387396.[Medline] [Order article via Infotrieve]
25. Nakanishi T, Gu H, Hagiwara N, Momma K. Mechanisms of oxygen-induced contraction of ductus arteriosus isolated from the fetal rabbit. Circ Res. 1993; 72: 12181228.
26. Ng L, Gurney AM. Store-operated channels mediate Ca2+ influx and contraction in rat pulmonary artery. Circ Res. 2001; 89: 923929.
27. McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, Yuan JX. Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L870L880.
28. Sweeney M, Yu Y, Platoshyn O, Zhang S, McDaniel SS, Yuan JX. Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2002; 283: L144L155.
29. Kunichika N, Yu Y, Remillard CV, Platoshyn O, Zhang S, Yuan JX. Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L962L969.
30. Xu SZ, Beech DJ. TrpC1 is a membrane-spanning subunit of store-operated Ca2+ channels in native vascular smooth muscle cells. Circ Res. 2001; 88: 8487.
31. Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2004; 286: L848L858.
32. Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JS. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res. 2004; 95: 496505.
33. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and non-muscle myosin, II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003; 83: 13251358.
| Footnotes |
|---|
This article has been cited by other articles:
![]() |
R. I. Clyman, N. Waleh, H. Kajino, C. Roman, and F. Mauray Calcium-dependent and calcium-sensitizing pathways in the mature and immature ductus arteriosus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1650 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kajimoto, K. Hashimoto, S. N. Bonnet, A. Haromy, G. Harry, R. Moudgil, T. Nakanishi, I. Rebeyka, B. Thebaud, E. D. Michelakis, et al. Oxygen Activates the Rho/Rho-Kinase Pathway and Induces RhoB and ROCK-1 Expression in Human and Rabbit Ductus Arteriosus by Increasing Mitochondria-Derived Reactive Oxygen Species: A Newly Recognized Mechanism for Sustaining Ductal Constriction Circulation, April 3, 2007; 115(13): 1777 - 1788. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |